Trident Texofab Limited has announced that the promoter group, represented by HARDIP DESAI FAMILY TRUST, has acquired an additional 0.26% of the company’s equity shares. This acquisition, executed through an open market transaction on August 17, 2026, increases the promoter group’s total holding to 6.79%. This move signifies sustained confidence and a strengthened commitment from the promoter to Trident Texofab’s future growth and stability.
Promoter Group Enhances Stake in Trident Texofab
Trident Texofab Limited has been notified of a significant share acquisition by its promoter group. The HARDIP DESAI FAMILY TRUST, a key entity within the promoter group, has successfully acquired an additional 39,425 shares, representing 0.26% of the total equity share capital. This transaction, conducted on the open market, aligns with the company’s continuous efforts to maintain strong promoter engagement and support.
Acquisition Details and Holding Post-Transaction
The acquisition took place on August 17, 2026. Prior to this transaction, the promoter group’s holding stood at 6.53%. Following the purchase, their total shareholding in Trident Texofab Limited has increased to 10,18,691 shares, constituting 6.79% of the company’s total voting capital. The equity share capital of Trident Texofab remains unchanged at Rs. 14,99,57,640/-, comprising 1,49,95,764 equity shares of Rs. 10/- each.
This increased stake underscores the promoter’s belief in the company’s operational performance and future prospects. The disclosure has been made in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, ensuring transparency and regulatory adherence.
Source: BSE
